Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs MOREPEN LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA MOREPEN LABS AJANTA PHARMA/
MOREPEN LABS
 
P/E (TTM) x 38.3 28.2 135.6% View Chart
P/BV x 8.3 2.9 291.3% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 AJANTA PHARMA   MOREPEN LABS
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-23
MOREPEN LABS
Mar-23
AJANTA PHARMA/
MOREPEN LABS
5-Yr Chart
Click to enlarge
High Rs1,42655 2,601.8%   
Low Rs1,06224 4,491.3%   
Sales per share (Unadj.) Rs297.227.7 1,071.9%  
Earnings per share (Unadj.) Rs46.70.8 6,172.0%  
Cash flow per share (Unadj.) Rs57.11.3 4,381.1%  
Dividends per share (Unadj.) Rs7.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs269.114.7 1,826.7%  
Shares outstanding (eoy) m125.91511.17 24.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.21.4 295.9%   
Avg P/E ratio x26.651.8 51.4%  
P/CF ratio (eoy) x21.830.1 72.4%  
Price / Book Value ratio x4.62.7 173.6%  
Dividend payout %15.00-   
Avg Mkt Cap Rs m156,63820,051 781.2%   
No. of employees `000NANA-   
Total wages/salary Rs m7,8511,547 507.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m37,42614,175 264.0%  
Other income Rs m98661 1,608.3%   
Total revenues Rs m38,41314,237 269.8%   
Gross profit Rs m7,833795 984.8%  
Depreciation Rs m1,308279 468.3%   
Interest Rs m5820 294.8%   
Profit before tax Rs m7,453558 1,336.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,573171 920.8%   
Profit after tax Rs m5,880387 1,520.3%  
Gross profit margin %20.95.6 373.0%  
Effective tax rate %21.130.6 68.9%   
Net profit margin %15.72.7 575.8%  
BALANCE SHEET DATA
Current assets Rs m28,2527,562 373.6%   
Current liabilities Rs m11,3933,212 354.7%   
Net working cap to sales %45.030.7 146.8%  
Current ratio x2.52.4 105.3%  
Inventory Days Days6618 363.4%  
Debtors Days Days10678 1.5%  
Net fixed assets Rs m18,7073,543 527.9%   
Share capital Rs m2531,022 24.7%   
"Free" reserves Rs m33,6246,507 516.7%   
Net worth Rs m33,8777,529 449.9%   
Long term debt Rs m139 133.8%   
Total assets Rs m47,04711,105 423.7%  
Interest coverage x128.629.1 441.3%   
Debt to equity ratio x00 29.7%  
Sales to assets ratio x0.81.3 62.3%   
Return on assets %12.63.7 344.8%  
Return on equity %17.45.1 337.9%  
Return on capital %22.27.7 289.4%  
Exports to sales %59.939.9 150.1%   
Imports to sales %11.530.5 37.6%   
Exports (fob) Rs m22,4205,657 396.4%   
Imports (cif) Rs m4,2934,324 99.3%   
Fx inflow Rs m22,4205,657 396.4%   
Fx outflow Rs m4,2934,444 96.6%   
Net fx Rs m18,1271,213 1,494.2%   
CASH FLOW
From Operations Rs m7,918-912 -868.5%  
From Investments Rs m-5,596-465 1,203.2%  
From Financial Activity Rs m-1,0791,435 -75.1%  
Net Cashflow Rs m1,24359 2,120.2%  

Share Holding

Indian Promoters % 66.2 38.2 173.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.8 4.3 595.4%  
FIIs % 9.1 2.1 431.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 33.8 61.8 54.7%  
Shareholders   54,351 304,289 17.9%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs MOREPEN LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs MOREPEN LABS Share Price Performance

Period AJANTA PHARMA MOREPEN LABS S&P BSE HEALTHCARE
1-Day 2.51% 0.26% 1.18%
1-Month 7.60% -14.25% -0.75%
1-Year 92.91% 70.98% 61.82%
3-Year CAGR 21.63% 9.94% 18.16%
5-Year CAGR 26.85% 18.97% 19.79%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the MOREPEN LABS share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 66.2% stake in the company. In case of MOREPEN LABS the stake stands at 38.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of MOREPEN LABS.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 7.0 per share. This amounted to a Dividend Payout ratio of 15.0%.

MOREPEN LABS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of MOREPEN LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.